Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
BLCO.TOthis companyBausch + Lomb Corporation	CA$28.83	-16.74×	0.94×	1.18×	18.09×	-58.7%	54.8%	3.7%	-7.1%	-5.6%	1.5%	-1.1%	0.83×	8.17×	0.45×	1.55×	0.0%	5	1.13	1	C-
BHC.TOBausch Health Companies Inc.	CA$11.86	16.14×	-4.65×	0.25×	6.55×	2885.5%	60.9%	21.3%	1.5%	-28.9%	3.2%	37.9%	-38.35×	5.8×	1.35×	1.47×	0.0%	5	0.45	2	C
EDT.TOSpectral Medical Inc.	CA$1.16	-8.47×	-5.93×	169.36×	-10.19×	-125.9%	-211.1%	-478.5%	-1953.0%	68.4%	26.8%	-2.3%	-0.3×	-0.4×	-2.26×	0.08×	0.0%	2	-136.84	2	C
OTC.VOcumetics Technology Corp.	CA$0.40	-13.7×	-18.65×	0×	-20.26×	-109.6%	0.0%	0.0%	0.0%	136.2%	-294.8%	-4.7%	-1.34×	-1.25×	-2.95×	0.23×	0.0%	1	-61.88	2	C
SONA.CNSona Nanotech Inc.	CA$0.27	-21.45×	-1,796.66×	0×	-25.66×	-102.9%	0.0%	0.0%	0.0%	8381.9%	-1239.4%	-2.8%	-7.94×	-0.07×	-89.24×	0.28×	0.0%	2	-74.3	2	C
TLRY.TOTilray Brands, Inc.	CA$4.08	-5.04×	0.38×	0.67×	61.08×	-3328.0%	26.3%	-6.0%	-13.3%	-7.5%	-2.7%	-16.6%	0.25×	13.16×	-2.31×	2.21×	0.0%	4	-2.19	2	C+
Peer median	—	-8.47×	-5.93×	0.25×	-10.19×	-109.6%	0.0%	0.0%	0.0%	68.4%	-2.7%	-2.8%	-1.34×	-0.07×	-2.31×	0.28×	0.0%	2	-61.88	2	—